Study of High-dose Olmesartan compared with Telmisartan on Blood pressure and Metabolism in Type 2 Diabetics with Hypertension
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Telmisartan (Primary)
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 27 Jan 2014 Planned End Date changed to 1 Jun 2011 as reported by University Hospital Medical Information Network - Japan record.
- 27 Jan 2014 Status changed from completed to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 02 Aug 2011 New trial record